Comparison of conventional, burst and high-frequency spinal cord stimulation on pain relief in refractory failed back surgery syndrome patients: study protocol for a prospective randomized double-blinded cross-over trial (MULTIWAVE study) | Trials
FDA approves Abbott's smallest rechargeable neurostimulator
Frontiers | Spinal Cord Stimulation as Treatment for Cancer and Chemotherapy-Induced Pain
Abbott's Neuromodulation group gets FDA approval for chronic pain app
Spinal Cord Stimulator Systems - Boston Scientific
FDA Approves Abbott's "Low Dose," Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life* for People Living with Chronic Pain - Sep 26, 2019
Abbott's spinal cord stimulator nets FDA green light for diabetes pain
Abbott Recalls Neurostim Devices After Complaints of Controllers Disconnecting | Medical Design & Development
Spinal cord stimulation: a nonopioid alternative for chronic pain management | CMAJ
Abbott's Neuromodulation Products | Abbott
FDA approves Abbott's spinal cord stimulator for non-surgical back pain | BioWorld